Financials Obio Technology (Shanghai) Corp., Ltd.

Equities

688238

CNE1000059N9

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-20 pm EDT 5-day change 1st Jan Change
5.59 CNY -3.79% Intraday chart for Obio Technology (Shanghai) Corp., Ltd. -5.73% -37.82%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 9,400 5,820 3,619 - -
Enterprise Value (EV) 1 9,400 5,820 3,619 3,619 3,619
P/E ratio 230 x -45.2 x -31.1 x 168 x -
Yield - - - - -
Capitalization / Revenue 32.3 x 27.3 x 10.1 x 7.73 x 9.76 x
EV / Revenue 32.3 x 27.3 x 10.1 x 7.73 x 9.76 x
EV / EBITDA 143 x -48.7 x 56.6 x 30.3 x -
EV / FCF - -9.14 x -17 x -22.6 x 113 x
FCF Yield - -10.9% -5.89% -4.42% 0.88%
Price to Book 4.33 x 2.82 x 1.86 x 1.42 x -
Nbr of stocks (in thousands) 641,146 647,433 647,433 - -
Reference price 2 14.66 8.990 5.590 5.590 5.590
Announcement Date 2/23/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 291.3 213 359.4 468.2 371
EBITDA 1 - 65.77 -119.4 63.91 119.4 -
EBIT 1 - 41.71 -156.1 -123 26.33 -
Operating Margin - 14.32% -73.26% -34.22% 5.62% -
Earnings before Tax (EBT) 1 - 41.62 -156.2 -123 17.38 -
Net income 1 54.26 39.03 -128 -116 19.88 -
Net margin - 13.4% -60.09% -32.28% 4.25% -
EPS 2 0.1077 0.0638 -0.1990 -0.1800 0.0333 -
Free Cash Flow 1 - - -637 -213 -160 32
FCF margin - - -299.01% -59.27% -34.18% 8.63%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/2/22 2/23/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - -637 -213 -160 32
ROE (net income / shareholders' equity) - 2.12% -6.06% -0.01% 1.63% -
ROA (Net income/ Total Assets) - 1.75% -4.98% -4.5% 0.4% -
Assets 1 - 2,233 2,573 2,578 4,928 -
Book Value Per Share 2 - 3.390 3.190 3.000 3.930 -
Cash Flow per Share 2 - 0.0300 -0.1400 -0.1600 0.1600 -
Capex 1 - 484 547 103 74 38
Capex / Sales - 166.29% 256.71% 28.66% 15.81% 10.24%
Announcement Date 3/2/22 2/23/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.59 CNY
Average target price
8.2 CNY
Spread / Average Target
+46.69%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688238 Stock
  4. Financials Obio Technology (Shanghai) Corp., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW